A Follow-up Trial to Assess the Persistence of the Immune Response to the Group B Streptococcus Vaccine (GBS-NN/NN2) After a Primary Vaccination of Healthy Pregnant Women, and to Assess Safety, Reactogenicity, and Immunogenicity of the GBS-NN/NN2 Vaccine When Administered During Follow-Up As a Booster Dose During a New Pregnancy
Latest Information Update: 26 Sep 2024
At a glance
- Drugs GBS NN (Primary)
- Indications Streptococcal infections
- Focus Pharmacodynamics
- Sponsors Minervax
- 26 Sep 2024 New trial record